A randomized, double-blind, placebo controlled dose-ranging study of the effects of MK7418, both as monotherapy and in combination with furosemide, on diuresis and renal function in patients with congestive heart failure and renal impairment treated with oral loop diuretics who require hospitalization for fluid overload
Latest Information Update: 13 Dec 2023
At a glance
- Drugs Rolofylline (Primary)
- Indications Heart failure; Renal impairment
- Focus Therapeutic Use
- Sponsors NovaCardia
- 28 Apr 2008 New trial record.